Induction of multiple PCR-SSCPE mobility shifts in p53 exons in cultures of normal human urothelium exposed to low-dose γ-radiation

International Journal of Radiation Biology

Volumn 72, Issue 1, 1997, Pages 21-31

  Colucci, S ^a   Mothersill, C ^a   Harney, J ^b   Gamble, S C ^c   Seymour, C ^a   Arrand, J E ^c  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN P53;

ARTICLE; CONTROLLED STUDY; DNA REPAIR; GAMMA IRRADIATION; GENETIC STABILITY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE; UROTHELIUM;

CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, RADIATION; EXONS; GAMMA RAYS; GENES, P53; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR SUPPRESSOR PROTEIN P53; UROTHELIUM;

EID: 0030789548     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530097143509     Document Type: Article

References (64)

1. ALBERTS, B., BRAY, D., LEWIS, J., RAFF, M., ROBERTS, K. and WATSON, J. D., 1989, Molecular Biology of the Cell, 2nd edn (New York: Garland).
2. BOUKAMP, P., PETRUSSEVSKA, R. T., BREITKREUTZ, D., HORNUNG, J., MARKHAM, A. and FUSENIG, N. E., 1988, Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. Journal of Cell Biology, 106, 761-771.
3. BRACEY, T. S., MILLER, J. C., PREECE, A. and PARASKEVA, C., 1995, Gamma radiation-induced apoptosis in human colorectal adenoma and carcinoma cell lines can occur in the absence of wild-type p53. Oncogene, 10, 2391-2396.
4. CHANG, W. P. and LITTLE, J. B., 1992, Delayed reproductive death as a dominant phenotype in cell clones surviving x-irradiation. Carcinogenisis, 13, 923-928.
5. CLARKE, A. R., PURDIE, C. A., HARRISON, D. J., MORRIS, R. G., BIRD, C. C., HOOPER, M. L. and WYLLIE, A. H., 1993, Thymocyte apoptosis induced by p53-dependent and independent pathways, Nature, 362, 847-849.
6. COTTER, T. G., GLYNN, J. M., ECHEVERR, F. and GREEN, D. H., 1992, The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Research, 12, 773-776.
7. CRAANEN, M. E., BLOK, P., DEKKER, W., OFFERHAUS, G. J. and TYTGAT, G. N., 1995, Chronology of p53 protein accumulation in gastric carcinogenesis. Gut, 36, 848-852.
8. DI LEONARDO, A., LINKE, S. P., CLARKIN, K. and WAHL, G. M., 1995, DNA damage triggers a prolonged p53-dependant G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes and Development, 8, 2540-2551.
9. DIX, B., ROBBINS, P., CARRELLO, S., HOUSE, A. and IACOPETTA, B., 1994, Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. British Journal of Cancer, 70, 585-590.
10. EL-DEIRY, W. S., HARPER, J. W., O'CONNOR, P. M., VELCULESCU, V. E., CANMAN, C. E., JACKMAN, J., PIETENPOL, J. A., BURRELL, M., HILL, D. E., WANG, Y., WIMAN, K. G., MERCER, W. E., KASTAN, M. B., KOHN, K. W., ELLEDGE, S. J., KINZLER, K. W. and VOGELSTEIN, B., 1994, WAF1/CIP1 induced in p53-mediated G1 arrest and apoptosis. Cancer Research, 54, 1169-1174.
11. EVAN, G. I., WYLLIE, A. H., GILBERT, C. S., LITTLEWOOD, T. D., LAND, H., BROOKS, M., WATERS, C. M., PENN, L. Z. and HANCOCK, D.C., 1992, Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
12. FINLAY, C. A., HINDS, P. W., TAN, T.-H., ELIAHU, D., OREN, M. and LEVINE, A. J., 1988, Activating mutations for transformation by p53 produce a gene product that forms an hsc70 p53 complex with an altered half-life. Molecular and Cellular Biology, 8, 531-539.
13. CANNON, J. V., GREAVES, R. and LANK, D. P., 1990, Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form. EMBO Journal, 9, 1595-1602.
14. GILL, G. and PTASHNE, M., 1988, Negative effect of the transcriptional activator GAL4. Nature, 334, 721-724.
15. HARNEY, J. V., MURPHY, D. M., JONES, M. and MOTHERSILL, C., 1995a, Expression of p53 in urothelial cell cultures from tumour-bearing and tumour-free patients. British Journal of Cancer, 71, 25-29.
16. HARNEY, J. V., SEYMOUR, G. B., MURPHY, D. M. and MOTHERSILL, G., 1995b, Variation in the expression of P53, C-myc, and Bcl-2 oncoproteins in individual patient cultures of normal human urothelium exposed to cobalt-60 gamma rays and N-nitrosodicthanolamine. Cancer Epidemiology, Biomarkers and Prevention, 4, 617-625.
17. HARPER, J. W., ADAMI, G. R., WEI, N., KEYOMARSI, K. and ELLEDGE, S. J., 1993, The p21 Cdk-interacting protein Gipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
18. HARRIS, G. G., 1993, p53: at the crossroads of molecular carcinogenesis and risk assessment. Science, 262, 1980-1981.
19. HARRIS, G. G. and HOLLSTEIN, M., 1993, Clinical implications of the p53 tumour suppressor gene. New England Journal of Medicine, 392, 1318.
20. HAYASHI, K., 1992, PGR-SSGP: a method for detection of mutations. GATA, 9, 73-79.
21. HINDS, P. W., FINLAY, C. A., QUARTIN, R. S., BAKER, S. J., FEARON, E.R., VOGELSTEIN, B. and LEVINE, A. J., 1990, Mutant p53 cDNAs from human colorectal carcinomas can cooperate with ras in transformation of primary rat cells. Cell Growth and Differentiation, 1, 571-580.
22. HOLLSTELN, M., SIDRANSKY, D., VOGELSTEIN, B. and HARRIS, C., 1991, p53 mutations and human cancer. Science, 253, 49-53.
23. IGGO, R., GATTER, K., BARTEK, J. and LANE, D. B. 1990, Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335, 675-679.
24. IWAYA, K., TSUDA, H., FUJITA, S., SUZUKI, M. and HIROHASHI, S., 1995, Natural state of mutant p53 protein and heat shock protein 70 in breast cancer tissues. Laboratory Investigations, 72, 707-714.
25. KASTAN, M. B., ONYEWERE, O., SIDRANSKY, D., VOGELSTEIN, B. and GRAIG, R. W., 1991, Participation of the p53 protein in the cellular response to DNA damage. Cancer Research, 51, 6304-6311.
26. KASTAN, M. B., XHAN, Q., EL-DEIRY, W. S., CARRIER, E., JACKS, T., WALSH, W. V., PLUNKETT, B. S., VOGELSTEIN, B. and FORNACE, A. J. JR., 1992, A mammalian cell cycle checkpoint utilizing p53 and GADD45 is detective in ataxia telangiectasia. Cell, 71, 587-597.
27. KERN, S. E., KINZLER, K. W., BAKER, S. J., NIGRO, J. M., ROTTER, Y., LEVINE, A. J., FRIEDMAN, P., PRIVES, C. and VOGELSTEIN, B., 1991, Mutant p53 proteins hind DNA abnormally in vitro. Oncogene, 6, 131-136.
28. KUERBITZ, S. J., PLUNKETT, B. S., WALSH, W. V. and KASTEN, M. B., 1992, Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proceedings of the National Academy of Sciences, USA, 89, 7491-7495.
29. LANE, D. P., 1992, P53, guardian of the genome. Nature, 358, 15-16.
30. LEHMAN, T. A., MODALI, R., BOUKAMP, P., STANEK, J., BENNETT, W. P., WELSH, J. A., METCALF, R. A., STAMPFER, M. R. and FUSENIG, N. E., 1993, p53 mutations in human immortalised epithelial cell lines. Carcinogenesis, 14, 833-839.
31. LEVINE, A. J., 1992, The p53 tumour suppressor gene and product. In Cancer Surveys, vol. 12. Tumour Suppressor Genes, the Cell Cycle and Cancer, edited by A. J. Levine (Cold Spring Harbor: Imperial Cancer Research Fund).
32. LEVINE, A. J., MOMAND, J. and FINLAY, C. A., 1991, The p53 tumour suppressor gene. Nature, 351, 453-456.
33. LIPPONEN, P. K., 1993, Over-expression of p53 nuclear oncoprotein in transitional-cell bladder carcinoma and its prognostic value. International Journal of Cancer, 53, 365-370.
34. LOWE, S. W., SCHMITT, E. M., SMITH, S. W., OSBORNE, B. A. and JACKS, T., 1993, p53 is required for radiation induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
35. LU, X. and LANE, D. P., 1993, Differential induction of transcriptionally active following UV or ionising radiation: defects in chromosome instability syndromes? Cell, 75, 765-778.
36. MATSUMOTO, H., WANG, X. and OHNISHI, T., 1995, Binding between wild-type p53 and hsp72 accumulated after UV and gamma-irradiation. Cancer letters, 92, 127-133.
37. MENDONCA, M. S., ANTONIONO, R. J. and REDPATH, J. L., 1993, Delayed heritable damage and epigenetics in radiation-induced neoplastic transformation of human hybrid cells. Radiation Research, 134, 209-216.
38. MCDONNELL, T. J., MARIN, M. C., HSU, B., BRISBAY, S. M., MCCONNELL, K., TU, S.-M., CAMPBELL, M. L. and RODRIGUEZ-VILLANEUVA, J., 1993, The bcl-2 oncogene: apoptosis and neoplasia. Radiation Research, 136, 307-312.
39. MILNER, J. and MEDCALF, E. A., 1992, Cotranslation of activated mutant p53 with wild-type drives the wild-type p53 protein into the mutant conformation. Cell, 65, 765-774.
40. MITSUDOMI, T., OYAMA, T., NISHIDA, K., OGAMI, A., OSAKI, T., NAKANISHI, R., SUGIO, K., YASUMOTO, K. and SUGIMACHI, K., 1995, P53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival. Annals of Oncology, 6 (suppl.) S9-13.
41. MOMAND, J., ZAMBETTI, G. P., OLSEN, D. C., GEORGE, D. and LEVINE, A. J., 1992, The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245.
42. MOTHERSILL, C., COLUCCI, S., ARRAND, J., GAMBLE, S., HARNEY, J., MURPHY, D. M. and SEYMOUR, C. B., 1996, Individual variation in the expression of proteins involved in the regulation of growth and apoptosis post-DNA damage in normal human urothelium. Radiation Oncology Investigation, 3, 404-407.
43. MOTHERSILL, C., HARNEY, J., LYNG, F., COTTELL, D., PARSONS, K., MURPHY, D. M. and SEYMOUR, C. B., 1995, Primary explants of human uroepithelium show an unusual response to low-dose irradiation with cobalt-60 gamma rays. Radiation Research, 142, 181-187.
44. MOTHERSILL, C., HARNEY, J. and SEYMOUR, C. B., 1994a, Induction of stable P53 oncoprotein and of c-myc over-expression in cultured normal human urothelium by radiation and N-nitrosodiethanolamine. Radiation Research, 138, 93-98.
45. MOTHERSILL, C., SEYMOUR, C. B., HARNEY, J. and HENNESSEY, T. P., 1994b, High levels of stable P53 protein and the expression of c-myc in cultured human epithelial tissue after cobalt-60 irradiation. Radiation Research, 137, 317-322.
46. MOTHERSILL, C., SEYMOUR, C. B., O'BRIEN, A. and HENNESSEY, T. P., 1991, Proliferation of normal and malignant human epithelial cells post irradiation. Acta Oncologica, 30, 851-858.
47. REICH, N. C. and LEVINE, A. J., 1984, Growth regulation of a cellular tumour antigen, p53, in non-transformed cells. Nature, 308, 199-201.
48. rd Meeting of the Radiation Research Society - Program and Abstracts, San José, p 85.
49. SARKIS, A. S., DALBAGNI, G., CORDON-CARDO, C., ZHANG, Z. F., SHEINFELD, J., FAIR, W. R., HERR, H. W. and REUTER, 1993, Nuclear over-expression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. Journal of the National Cancer Institute, 85, 53-59.
50. SEYMOUR, C. B. and MOTHERSILL, C., 1989, Lethal mutations, the survival curve shoulder and split dose recovery. International Journal of Radiation Biology, 56, 999-1010.
51. SIDRANSKY, D., VON ESCHENBAGH, A., TSAI, T. C., JONES, P., SUMMER-HAVES, I., MARSHALL, F., PAUL, M., GREEN, P., HAMILTON, S. R., FROST, P. and VOGELSTEIN, B., 1991, Identification of p53 gene mutation in invasive bladder cancers and urine samples. Science, 252, 706-709.
52. SMITH, M. L. and FORNACE JR, A. J., 1995, Genomic instability and the role of p53 mutations in cancer cells. Current Opinions in Oncology, 7, 69-75.
53. SUGANO, T., NITTA, M., OHMORI, H. and YAMAIZUMI, M., 1995, Nuclear accumulation of p53 in normal human fibroblasts is induced by various cellular stresses which evoke the heat shock response, independently of the cell cycle, Japanese Journal of Cancer Research, 86, 415-418.
54. SUGAHARA, T. and WANATABE, M., 1994, Epigenetic nature of radiation carcinogenisis at low doses. Chinese Medical Journal, 107, 405-410.
55. TAINSKY, M. A., BISCHOFF, F. Z. and STRONG, L. C., 1995, Genomic instability due to germline p53 mutations drives preneoplastic progression towards cancer in human cells. Cancer Metastasis-Reviews, 14, 43-48.
56. TOP, B., MOOI, W. J., KLAVER, S. G., BOERRIGTER, L., WISMAN, P., ELBERS, H. R., VISSER, S. and RODENHUIS, S., 1995, Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell-lung cancer. International Journal of Cancer, 64, 83-91.
57. WAGNER, A. J., SMALL, M. B. and HAY, N., 1993, Myc-mediated apoptosis is blocked by ectopic expression of bcl-2. Molecular and Cellular Biology, 13, 2432-2440.
58. WALKER, R. A., DEARING, S. J., LANE, D. P. and VARLEY, J. M., 1991, Expression of p53 protein in infiltrating and in-situ breast carcinomas. Journal of Pathology, 165, 203-211.
59. WALTON, M. I., WHYSONG, D., O'CONNOR, P. M., HOCKENBERRY, D., KORSMEYER, S. J. and KOHN, K. W., 1993, Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Research, 53, 1853-1861.
60. WANG, Y., SZEKELY, L., OKAN, I., KLEIN, G. and WIMAN, K. G., 1993, Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc induced T-cell lymphoma line. Oncogene, 8, 3427-3431.
61. WAZER, D. E., CHU, Q., LIU, X. L., GAO, Q., SAFAH, H. and BAND, V., 1994, Loss of p53 protein during radiation transformation of primary human mammary epithelial cells. Molecular and Cellular Biology, 14, 2468-2478.
62. WEINERT, T. and LYDALL, D., 1993, Cell cycle checkpoints, instability and cancer. Seminars on Cancer Biology, 4, 129-140.
63. WILLIAMS, G. T. and SMITH, C. A., 1993, Molecular regulation of apoptosis: genetic controls on cell death. Cell, 74, 777-779.
64. XU, L., CHEN, Y. T., HUVOS, A. G., ZLOTOLOW, I. M., RETTIG, W. J., OLD, L. J. and GARIN-CHESA, P., 1994, Overexpression of p53 protein in squamous cell carcinomas of the head and neck without apparent gene mutations. Diagnostic and Molecular Pathology, 3, 83-92.